Planning for success: overcoming challenges to recruitment and conduct of an open-label emergency department–led paediatric trial by Roper, Louise et al.
   1Roper L, et al. Emerg Med J 2020;0:1–7. doi:10.1136/emermed-2020-209487
Original research
Planning for success: overcoming challenges to 
recruitment and conduct of an open- label emergency 
department–led paediatric trial
Louise Roper,1 Mark D Lyttle,2,3 Carrol Gamble,4 Amy Humphreys,4 Shrouk Messahel,5 
Elizabeth D Lee,5 Joanne Noblet,5 Helen Hickey,4 Naomi Rainford,4 Anand Iyer,6 
Richard Appleton,6 Kerry Woolfall  1
To cite: Roper L, 
Lyttle MD, Gamble C, et al. 
Emerg Med J Epub ahead 
of print: [please include Day 
Month Year]. doi:10.1136/
emermed-2020-209487
Handling editor Edward 
Carlton
 ► Additional material is 
published online only. To view 
please visit the journal online 
(http:// dx. doi. org/ 10. 1136/ 
emermed- 2020- 209487).
1Institute of Population Health & 
Society, University of Liverpool, 
Liverpool, UK
2Emergency Department, Bristol 
Royal Children’s Hospital, Bristol, 
UK
3Faculty of Health and Applied 
Sciences, University of the West 
of England, Bristol, UK
4Liverpool Clinical Trials Centre, 
University of Liverpool, Liverpool, 
UK
5Emergency Department, Alder 
Hey Children’s NHS Foundation 
Trust, Liverpool, UK
6Department of Neurology, 
Alder Hey Children’s NHS 
Foundation Trust, Liverpool, UK
Correspondence to
Dr Kerry Woolfall, University of 
Liverpool, Liverpool L69 3BX, 
UK;  k. woolfall@ liverpool. ac. uk
Received 29 January 2020
Revised 3 August 2020
Accepted 1 September 2020
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY. 
Published by BMJ.
ABSTRACT
Background Key challenges to the successful conduct 
of The Emergency treatment with Levetiracetam or 
Phenytoin in Status Epilepticus in children (EcLiPSE) trial 
were identified at the pre- trial stage. These included 
practitioner anxieties about conducting research without 
prior consent (RWPC), inexperience in conducting an 
ED- led trial and use of a medication that was not usual 
ED practice. As part of an embedded study, we explored 
parent and practitioner experiences of recruitment, 
RWPC and conduct of the trial to inform the design and 
conduct of future ED- led trials.
Methods A mixed- methods study within a trial 
involving (1) questionnaires and interviews with parents 
of randomised children, (2) interviews and focus groups 
with EcLiPSE practitioners and (3) audio- recorded trial 
discussions. We analysed data using thematic analysis 
and descriptive statistics as appropriate.
Results A total of 143 parents (93 mothers, 39 
fathers, 11 missing information) of randomised children 
completed a questionnaire and 30 (25 mothers, 5 
fathers) were interviewed. We analysed 76 recorded trial 
recruitment discussions. Ten practitioners (4 medical, 6 
nursing) were interviewed, 36 (16 medical, 20 nursing) 
participated in one of six focus groups. Challenges to the 
success of the trial were addressed by having a clinically 
relevant research question, pragmatic trial design, 
parent and practitioner support for EcLiPSE recruitment 
and research without prior consent processes, and 
practitioner motivation and strong leadership. Lack of 
leadership negatively affected practitioner engagement 
and recruitment. EcLiPSE completed on time, achieving 
its required sample size target.
Conclusions Successful trial recruitment and conduct 
in a challenging ED- led trial was driven by trial design, 
recruitment experience, teamwork and leadership. 
Our study provides valuable insight from parents and 
practitioners to inform the design and conduct of future 
trials in this setting.
INTRODUCTION
Recruitment to multicentre randomised controlled 
trials is challenging, and poor recruitment can lead 
to reduced confidence in the results, costly exten-
sions or early closure.1 Trial recruitment can be 
hindered by patient and trial practitioner–related 
factors including poor quality participant infor-
mation, practitioner workload pressures, lack of 
equipoise, lack of leadership, or poor collaboration 
between clinical specialities and research teams.2 3 
Trials conducted in paediatric emergency medicine 
encounter additional practical and ethical chal-
lenges, including the need to perform research 
in life- threatening situations. To help ensure this 
research can be conducted, clinical trials legis-
lation enables children to be enrolled into some 
Key messages
What is already known on this subject
 ► The ‘Emergency treatment with Levetiracetam 
or Phenytoin in Status Epilepticus in children 
(EcLiPSE)’ trial was one of the first UK 
paediatric clinical trials of an interventional 
medicinal product to be conducted since 
legislation change enabling research without 
prior consent (RWPC) .
 ► Pre- trial research identified challenges to the 
success of EcLiPSE including use of an anti- 
epileptic medication (levetiracetam), which 
was not the standard medication in this clinical 
setting; practitioner anxieties about RWPC 
and inexperience of conducting an ED- led 
trial; healthcare staff rotational posts; and 
availability to seek consent.
What this study adds
 ► In this mixed- methods embedded study to 
explore parent and practitioner involvement in 
EcLIPSE.
 ► Challenges to trial success were overcome 
through trial design, recruitment experience, 
parental support for RWPC, and teamwork and 
leadership.
 ► Our study provides valuable insight from 
parents and practitioners to inform the design 
and conduct of future trials in this setting, 
including consideration of how the study 
and RWPC could be briefly communicated 
to parents of children who are regular ED 
attenders at the point of randomisation if 
deemed appropriate.
 ► Further research is needed to evaluate whether 
findings and recommendations translate to 
other ED- led trials of treatments for critically ill 
children.
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trials without prior informed consent.4 5 Research without prior 
consent (RWPC) is largely acceptable to parents and children, 
yet they may have concerns if trial interventions are not part 
of routine clinical care.6 7 Studies have also shown how practi-
tioners without experience of RWPC may have negative percep-
tions of this consent method,8 9 particularly if trial interventions 
represent significant changes to clinical practice.5
The ‘Emergency treatment with Levetiracetam or Phenytoin 
in Status Epilepticus in children (EcLiPSE)’ was an open- label, 
clinician- led trial and one of the first UK critical care trials 
of an interventional medicinal product to be conducted since 
legislation change enabling RWPC. Challenges to the success 
of EcLiPSE trial were identified in pre- trial research10 and site 
training.11 These included use of an anti- epileptic medication 
(levetiracetam), which was not the standard medication; inex-
perience of conducting an ED- led trial in a paediatric neuro-
logical emergency; practitioner anxieties about RWPC, including 
how parents would react to trial processes taking place without 
their consent, such as the opening of a randomisation envelope; 
healthcare staff rotational posts; and availability to seek consent. 
Despite these challenges, the EcLiPSE trial successfully recruited 
to target on time.
EcLiPSE included a mixed- methods embedded study (the 
Consent Study) involving parents of randomised children and 
EcLiPSE practitioners to explore experiences of recruitment, 
RWPC and trial conduct to inform the design and conduct of 
future ED- led trials. In this manuscript, we explore Consent 
Study data to identify key obstacles and enablers for successful 
trial conduct. A framework to enhance practitioner explanations 
and parental understandings of research without prior consent is 
reported in a separate manuscript (in press).
METHODS
Study design, setting and selection of participants
A mixed- methods embedded study (the Consent Study) took 
place in all 30 EcLiPSE sites between July 2015 and April 2017. 
This involved questionnaires and interviews with parents of 
randomised children, interviews and focus groups with EcLiPSE 
practitioners, and audio- recorded trial discussions. KW (female 
social scientist, PhD) and LR (female health psychologist, PhD) 
developed questionnaires (online supplemental file 1), and 
interview and focus group topic guides, using previous relevant 
studies5 and EcLiPSE feasibility work, which outlined parents’ 
views on trial acceptability and feasibility, including poten-
tial burden of the intervention and approach to consent10 (see 
example questions in online supplemental file 2). Topic guides 
and questionnaires explored experiences of trial recruitment and 
consent process, trial acceptability, and perceived barriers and 
facilitators to trial conduct. Recorded trial discussions between 
parents and recruiting practitioners enabled additional insight 
into trial recruitment and RWPC conversations.
Parents/legal representatives who did and did not consent 
to their child’s participation in the trial, and all practitioners 
involved in screening, recruiting, randomising and consenting 
were eligible to take part. Verbal consent was sought for audio 
recording trial conversations between parents and recruiting 
practitioners before study discussions began. If verbal consent 
was provided, a digital recorder was used to record trial discus-
sions. Written consent was then sought for all Consent Study 
elements as part of the EcLiPSE consent process. Recruitment 
for the Consent Study began at the same time sites began recruit-
ment to EcLiPSE. This included written parental consent for 
the use of recorded trial discussion data, completion of Consent 
Study questionnaires before hospital discharge and inter-
views conducted approximately 1 month after enrolment. LR 
conducted practitioner and parent interviews over the telephone, 
while practitioner focus groups were conducted face to face in 
hospital training rooms. Consent for audio recording interviews 
and focus groups was sought before interviews began. Towards 
the end of the first year of recruitment, LR identified large 
and small sites based on attendance numbers, as well as those 
with high and low EcLiPSE recruitment rates; and contacted 
lead research nurses or principal investigators to arrange inter-
views and focus groups. Before interviews and focus groups, LR 
explained the Consent Study aims and objectives and research 
processes (eg, consent and confidentiality). As trial recruitment 
progressed, LR stopped interviewing parents and practitioners 
from high recruiting sites and purposively sampled across all 
recruiting sites to ensure sample variance. Interviews and focus 
groups were audio recorded and transcribed verbatim by a 
professional transcription company (Voicescript, Bristol, UK). 
LR anonymised and checked transcripts for accuracy. Quali-
tative (interviews, focus groups and recorded trial discussion) 
recruitment stopped when data saturation was reached (the 
point where no new major themes were identified in ongoing 
analysis). Questionnaire recruitment took place throughout the 
EcLiPSE trial recruitment period.
Data analysis
Our approach to qualitative data analysis was thematic and 
iterative, referring back and forth between developing analysis, 
across all quantitative and qualitative datasets for evidence of 
challenges and enablers to successfully conducting research in 
emergency situations (see table 1). NVivo software assisted data 
organisation. LR entered questionnaire data into SPSS. The 
Consent Study research team (KW, LR) conducted the analysis 
to ensure analytical rigour. Our approach to synthesising qual-
itative and quantitative data drew on the constant comparative 
method.12 13 For this analysis, we particularly focused on qual-
itative and quantitative data to provide insight on enablers and 
barriers to recruitment and trial conduct. Additional analysis 
related to practitioner explanations and parental understand-
ings of research without prior consent are reported in a separate 
manuscript (in press). We present selected interview quotations 
(with pseudonyms) that illustrate research themes across a range 
of participants within the results. Where quotes have been short-
ened for brevity or to remove identifiable information, omitted 
text is marked with ‘…’ and explanatory text is in brackets. 
Participants were given consecutive identifying numbers, but 
cross- checked when presenting quotations for this manuscript to 
ensure no participant was cited twice with different identifying 
numbers. Descriptive statistics are presented with percentages.
Patient and public involvement
Details of patient and public involvement activities are reported 
in our linked publication (in press).
RESULTS
A total of 218 parents of 289 (75%) randomised and treated 
children consented to participate in some aspect of the Consent 
Study, and 143 parents completed a questionnaire (figure 1). We 
reached data saturation14 at 76 recorded trial discussions, 30 
parent (25 mothers, 5 fathers) interviews, 6 practitioner focus 
groups (n=36) and 10 practitioner telephone interviews. All 
parents interviewed had completed a questionnaire. Practitioners 
(nurses, n=26; doctors, n=20) included Principal Investigators, 
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Emergency Medicine doctors, and clinical and research nurses. 
Focus groups were held a mean 12 months and 9 days (range 
329–420) after site opening. Telephone interviews took place 
5–16 months (mean 8 months and 21 days, range 168–490 days) 
after site opening. No practitioners in our sample had prior 
experience of RWPC in paediatric trials.
Importance of a clinically relevant research question and 
pragmatic trial design
Practitioners described how the EcLiPSE Study addressed “a 
really important question that people want answered” (Focus 
group 3, female, doctor P4). This importance appeared to facil-
itate buy- in and enthusiasm for trial recruitment. Parents also 
spoke of how the trial aimed to answer a clinical question which 
they felt was important, with many explaining how they valued 
research that explores treatments for their child’s condition.
“I think the importance is I guess the clinical question. I think [this] 
is when you get maximum engagement from the clinical team” 
(Practitioner telephone interview, male, lead research nurse, P9).
“As the mother of a child that goes into Status and gets severe sei-
zures it’s nice to know that people are looking at studies” (Recorded 
trial discussion 41, parent).
Parents whose children had regular seizures described how 
they saw potential for their child to benefit from trial findings 
in the future “if it happened again” (Parent interview, mother, 
P28). Our pre- trial feasibility work10 had identified inexperience 
of conducting research during resuscitation as a potential chal-
lenge to recruitment. However, during focus groups and inter-
views, many practitioners described how EcLiPSE trial processes 
had been easy to follow in an emergency situation. A pragmatic 
design, which fitted closely to usual clinical practice and did not 
involve “extra work” (Focus Group 2, female, nurse, P4), was 
valued and appeared to assist practitioner engagement.
AWARENESS OF RANDOMISATION IN THE ED
An evaluation of EcLiPSE site training11 indicated practitioners 
were concerned that if parents noticed randomisation enve-
lopes being opened in the ED, they would object to the trial, or 
RWPC. They feared this would cause friction in a highly emotive 
life- threatening situation.
“You're like oh my God, what are they [parent] going to say, what 
are they going to do” (Practitioner telephone interview, female, lead 
research nurse, P8).
However, when reflecting on their experience of randomi-
sation, practitioners described how such initial concerns were 
often not realised as “parents are focussed on their child” (Focus 
group 2, male doctor, P1) and if they had noticed the envelope, 
it was often a passing recognition. Such findings were supported 
by the majority of parents who recalled how they “didn’t really 
have the time or inclination to think about it” (Parent interview, 
mother, P19).
The few parents in our sample who had noticed randomisation 
taking place in the ED were mainly those with previous experi-
ence of their child being admitted to hospital with seizures.
“When you've got a parent who has a child that’s a known epileptic 
and so they know all of the normal words that are said around that 
and then suddenly it’s a different one and they're like what does that 
mean?” (Focus group 5, nurse, P6)
In the cases when a parent did notice a change, a brief discus-
sion about the study, including what drug had been allocated, 
made parents feel that practitioners “were keeping me involved” 
(Parent interview, mother, P15). This communication appeared 
to alleviate any potential concerns or negative responses.
“It was after, obviously, the doctor had told me but I had seen them 
open the envelope, which is obviously new… I think as they opened 
the letter they would tell me what drug they were using, they always 
do” (Parent interview, mother, P7).
Practitioners described how the provision of brief informa-
tion about EcLiPSE and being “really transparent” (Focus group 
2, female, nurse, P6) when experienced parents noticed some-
thing different was important in maintaining parental trust. 
However, it was not always possible for practitioners to know 
whether parents had noticed trial processes were taking place. 
One parent had noticed the randomisation process, but had not 
Table 1 Approach to data analysis and synthesis
Phase Description
1. Familiarising with qualitative 
data
LR read interview, focus group, audio recorded consent discussion transcripts noting down initial ideas on themes
2. Generating initial codes Initially, three complementary data- coding frameworks were developed (for focus group, interview and audio- recorded consent discussion 
data) using broad a priori codes identified from initial reading related to the Consent Study aims and objectives. During the familiarisation 
stage, LR and KW identified data- driven codes and concepts. Analysis was based on thematic analysis, a method for identifying, analysing and 
reporting patterns (or themes) within data
3. Developing the coding 
framework
LR coded three transcripts in each data set and shared the initial coding frameworks with KW. KW second coded transcripts using the initial 
coding frames and made notes on any new themes identified and how the framework could be refined
4. Defining and naming themes Following review and reconciliation by LR, revised coding frames were subsequently developed and ordered into themes (nodes) within the 
NVivo Database. Regular meetings were held to discuss the developing frameworks
5. Completion of coding of 
transcripts
LR completed coding transcripts. For this manuscript, KW reviewed coding specific to challenges and enablers of conducting the trial and 
conducted further coding across datasets and made notes on in preparation for writing this manuscript
6. Quantitative data analysis LR entered questionnaire data into SPSS. Descriptive statistics were conducted including χ2 test for trend
7. Data synthesis Our approach to synthesising qualitative and quantitative data25 drew on the constant comparative method.12 13 This involved KW looking 
across quantitative and qualitative datasets for themes/data output related to challenges and enablers to successfully conducting research 
in paediatric emergency situations. This included exploring qualitative themes and quantitative output related to parent and practitioner 
experiences of recruitment, RWPC and conduct of the trial. Analysis was interpretive—theorising the significance of the patterns and their 
broader meanings and implications
8. Write- up LR and KW developed the initial manuscript. KW led the final development of themes and write- up phase in collaboration with LR and MDL.
RWPC, research without prior consent.
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asked questions on noticing the clinical team were whispering 
about something; this led to parental suspicion:
“I'm like what’s all this whispering about? What’s the dodgy enve-
lope? My kid is unconscious, tell me what’s going on. So it definitely 
made me uncomfortable” (Recorded trial discussion 52, parent).
Parent and practitioner support for EcLiPSE recruitment and 
consent processes
Just over one- third of parents (56/143, 39%) who completed 
a questionnaire indicated they were surprised to find out 
their child had been enrolled into a trial. However, almost all 
(139/143; 97%) agreed with the questionnaire statement that 
they “understood why consent for my child’s participation in 
EcLiPSE was sought after the treatment was given”, while the 
majority (129/143, 90%) also indicated they were satisfied with 
the EcLiPSE consent process. In contrast, one mother described 
her sense of loss of control over the situation as “They’d done it 
without telling us” (Parent interview, mother, P11). However, 
she explained how she provided consent for the use of her child’s 
data in EcLiPSE as “They use these two medications all the time”, 
which she found reassuring. As the following quote illustrates, 
the majority of parents stated that in such a life- threatening situ-
ation, parents prioritised the emergency treatment of their child 
over research consent processes:
“Well I prefer them to do whatever they can. It doesn’t really matter 
too much about consent, as long as they can do what they can to 
stop a seizure or to help stabilise, that is the first and foremost” 
(Parent interview, mother P3).
Support for RWPC was also described during practitioner 
interviews and focus groups, which was mainly attributed to 
“really positive responses” (Practitioner telephone interview, 
female, doctor, P9) from parents to RWPC discussions.
Adapting to research: going above and beyond
Evaluation of site initiation training11 highlighted concerns 
surrounding research personnel being available to support clin-
ical teams, leading to patients being missed, or inability to seek 
consent during evenings, weekends and the busy winter period. 
Despite best efforts, a minority of sites described how they strug-
gled to work as a team due to lack of research support or engage-
ment by key practitioners.
“I think not having [nurse] working in research, well that hasn’t 
helped, I mean just having him there two days that has kind pro-
tected time… But even when he was working with us, I don’t think 
we were necessarily always completing a log screen for every single 
case” (Practitioner telephone interview, male, lead research nurse, 
P9).
However, most sites overcame these challenges and success-
fully recruited to target, with some sites involved in multiple 
clinical trials having sufficient research cover at weekends. More 
commonly, practitioners described how they had “come in on 
your time off ” (Practitioner telephone interview, female, doctor, 
P6). Some high recruiting sites developed methods to maintain 
trial awareness and ensure eligible patients were not missed, 
including placing study materials in common areas or resusci-
tation rooms (eg, posters and leaflets), small non- financial staff 
incentives, and raising awareness of their recruitment perfor-
mance in comparison with their own target, and other sites.
Facilitating trial conduct through leadership
Despite some initial concerns about capacity, site leads acted 
as advocates for the study, maintaining awareness and regular 
training:
“We had taken on the study so we were very keen to do it. Even 
though we internally had our concerns, we were very strong at pro-
moting it after we had that initial site visit” (Practitioner telephone 
interview, female, doctor, P3).
Practitioners emphasised the importance of Principal Investi-
gators taking responsibility for promoting the trial and recruit-
ment of patients 24/7. This was often challenging in EDs working 
at full capacity. Examples included Principal Investigators 
preparing resuscitation teams when a potentially eligible child 
was on their way to the ED in order to briefly refresh people’s 
minds about the trial and clarify details of the scenario that may 
unfold.
“Just, if after the alert, you’d said to whichever nurses are in resus, 
okay, we’ve got a fitter, we might be doing the EcLiPSE study, are 
Figure 1 Participant characteristics by method in chronological order.
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you all aware of that? … What’s going to happen is…” (Focus group 
6, male, doctor, P1).
Strong leadership was not evident at a few sites, which gener-
ated negative impact on practitioner engagement, and lower 
numbers enrolled. Although such examples were rare, they 
highlight the importance of identifying a motivated Principal 
Investigator who is willing to make time to support the study 
throughout trial conduct.
“Sorry to be a bit miserable about it, but we do struggle a little bit 
with maintaining any enthusiasm… nobody is taking ownership re-
ally” (Practitioner telephone interview, female, lead research nurse, 
P1).
DISCUSSION
This study provides insight into the key factors which enabled 
successful conduct of a challenging ED- led paediatric emergency 
care trial drawing on the perspectives of parents of participants, 
and trial practitioners. Multiple factors, including trial design, 
tailored communication with parents of regular attenders, 
research support, teamwork and leadership, contributed strongly 
to successful conduct at each site and across the trial as a whole. 
There was a perceived negative impact on team engagement and 
recruitment where such factors were lacking.
Importantly, both parents and practitioners wanted to know 
the answer to the research question, a factor that appeared to 
underpin many of the decisions and behaviours captured in our 
embedded study. For example, the perceived importance of the 
clinical question appeared to influence parents’ consent deci-
sion as many believed their child may benefit from trial find-
ings in the future. This was not a misconception for parents 
of eligible children with a chronic health condition, as it was 
feasible that the trial results could inform changes to clinical care 
decisions within their lifetime. Our findings also suggested that 
practitioners were engaged and invested in EcLiPSE due to its 
design. The trial was open label, pragmatic and clinician led, 
and aimed to answer an important question that they believed 
would quickly inform their clinical practice. This engagement 
was apparent across the majority of EcLiPSE sites, despite initial 
concerns about whether the trial was possible which were often 
confounded by inexperience of conducting an ED- led trial. Our 
findings highlight the important role of researchers and funding 
panels in identifying clinically important research questions and 
suggest that challenging trials are more likely to succeed if all key 
stakeholders, including patients, family members and clinicians, 
prioritise the research question.15
Literature on pragmatic clinical trials has emphasised the 
importance of understanding the trial context.16 ED practi-
tioners valued how the EcLiPSE trial protocol was easy to 
follow, as it fitted closely to the usual emergency care algorithm 
for Status Epilepticus. Our findings suggest that work under-
taken by the EcLiPSE team, which included ED nurses, doctors, 
neurologists and triallists, who streamlined intervention delivery 
and data collection processes to minimise burden, contributed to 
successful recruitment and conduct in this setting.
As shown in recent pilot studies exploring treatments for 
paediatric suspected infection,17 18 parents and practitioners 
found RWPC to be acceptable, preventing unethical delays in the 
delivery of life- saving treatments. Our study adds to this litera-
ture by providing further insight into RWPC processes through a 
mixed- methods approach, including audio- recorded recruitment 
discussions and interviews with both parents and recruiting prac-
titioners. We found that initial practitioner concerns that parents 
would notice the randomisation envelope and object to the trial, 
or RWPC, were most often unfounded. Parents of children with 
frequent seizures appeared more likely to notice something 
different was occurring in the ED, such as the opening of the 
randomisation envelope. These parents valued how practitioners 
provided them with brief description of the study, including 
what drug had been allocated. One instance where such commu-
nication had not occurred had resulted in parental suspicion and 
potential breakdown of a trust in practitioners. Practitioners 
confirmed that brief information sheets and EcLiPSE posters 
were on display, although few parents noticed or read them. As 
shown in other studies exploring trial recruitment and decision- 
making,19 20 patients and family members often prioritise verbal 
over written information provision. The highly stressful and 
time- critical ED context is likely to have impacted on parental 
capacity and indeed desire to read even short written study 
information.5 Future trials would benefit from considering how 
their study and RWPC could be briefly communicated to parents 
of children who are regular ED attenders at the point of rando-
misation if deemed appropriate. Box 1 contains suggested brief 
information used in EcLiPSE practitioner training, which has 
been adapted for future ED trials.
Lemiex- Charles and McGuire’s Integrated Team Effectiveness 
Model (ITEM)21 provides a conceptual framework to aid the 
assessment of teams in healthcare. ITEM outlines the interplay 
between task (eg, trial) design and processes in achieving team 
effectiveness, while highlighting the importance of organisational 
context in which teams are embedded. At some sites, EcLiPSE 
recruitment was challenged by lack of ringfenced research staff 
time, or a lack of engagement of key site leads, which led to 
lower recruitment at these sites. Nevertheless, the majority of 
sites did not experience or overcome such challenges. Many 
went above and beyond their expected roles, by working in their 
own time,22 developing internal team rota systems and team 
incentives to facilitate recruitment. Although we believe this was 
intrinsically linked to practitioner engagement and support for 
a pragmatic trial, qualitative data suggest that leadership from 
the trial team and site Principal Investigators were also contrib-
uting factors. Indeed, a lack of leadership at a few sites nega-
tively impacted on practitioner engagement. Practitioners valued 
regular communication and support from the EcLiPSE team, 
which included members of the Pediatric Emergency Research in 
the UK and Ireland (PERUKI) research collaborative.23 As shown 
in other studies,24 regular multidisciplinary meetings, including 
teleconference or annual face- to- face PERUKI meetings, were 
viewed as a useful method of sharing good practice and main-
taining enthusiasm.
Box 1 Communication of RWPC to parents of regular 
attenders in the ED
If deemed appropriate, consider explaining how:
 ► We are conducting a study looking at [add key aim].
 ► Currently treating your child is the priority. We will of course 
talk to you about the study as soon as possible after the 
emergency situation has passed.
 ► If you would like further information about the study now, 
we have an information leaflet [direct parent to leaflet and/
or posters].
If parents state that they do not want their child included while 
in the ED, then they should not be included.
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Limitations and future directions
Our embedded study is potentially limited as it relates to only 
one ED- led trial of treatments for Status Epilepticus in the 
UK. Further research is needed to evaluate whether findings 
and recommendations translate to other ED- led trials of treat-
ments for critically ill children. Our study was strengthened by 
a mixed- methods approach to gain insight into both parent and 
practitioner experiences of trial recruitment and conduct. All 
sites participated in the Consent Study and practitioners were 
purposively sampled for focus groups and interviews to ensure 
sample variance (eg, low and high recruiting sites). However, LR 
and KW were members of the EcLiPSE team; therefore, despite 
confidentiality assurances, their roles may have impacted on 
practitioners’ willingness to discuss problems with trial recruit-
ment, conduct or record trial discussions with parents. The 
majority of parents (75%) of children randomised and treated 
in the EcLiPSE trial consented to participate in some aspect of 
the Consent Study and qualitative recruitment stopped when 
data saturation was reached.14 However, none of the 19/286 
(4%) parents who declined their child’s involvement in EcLiPSE 
consented to take part in the Consent Study; therefore, their 
views were not represented.
CONCLUSIONS
A pragmatic trial design, clear communication with parents, 
teamwork, research nurse support and leadership were key 
factors in successful recruitment and conduct of a challenging 
ED- led trial. Our study provides valuable insight from parents 
and practitioners to inform the design and conduct of future 
trials in this setting.
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